ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

JAVELIN Trial Design and Safety Results in Gastric Cancer

Hendrik-Tobias Arkenau, MD, PhD
Published Online:8:19 PM, Tue July 19, 2016

Hendrik-Tobias Arkenau, MD, PhD, founding medical director, executive medical director, Sarah Cannon Research Institute UK, gives an overview of the JAVELIN trial in gastric cancer. He also discusses the safety profile of avelumab.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.